Back to results
US 5,292,726 AGranted
N,N-diacylpiperazines
AssigneeMerck & Co., Inc.
InventorsWallace T. Ashton, Conrad P. Dorn, William J. Greenlee, Malcolm MacCoss, Sander G. Mills, Mu T. Wu
Life of this patent
Estimating the term…
Abstract
Diacylpiperazines of general structure ##STR1## are: angiotensin II (A-II) antagonists selective for the type 2 (AT.sub.2) subtype useful in the treatment of cerebrovascular, cognitive, and CNS disorders; tachykinin receptor antagonists useful in the treatment of inflammatory diseases and pain or migraine; and calcium channel blockers useful in the treatment of cardiovascular conditions such as angina, hypertension or ischemia.
Claims16
A compound of structural formula:
- ##STR23## or a pharmaceutically acceptable salt thereof, wherein:
- R.sup.1a is
- 1) H,
- 2) C.sub.1-8 alkyl,
- 3) phenyl, either unsubstituted or substituted with one or two substituents selected from:
- a) --C.sub.1-4 alkyl,
- b) halo,
- e) --OH,
- d) --CF.sub.3,
- e) --NH.sub.2,
- f) --NH(C.sub.1-4 alkyl),
- g) --N(C.sub.1-4 alkyl).sub.2,
- h) --CO.sub.2 H,
- i) --CO.sub.2 (C.sub.1-4 alkyl), and
- j) --C.sub.1-4 alkoxy;
- or
- 4) C.sub.1-4 alkyl-phenyl, wherein the phenyl is either unsubstituted or substituted with one or two substituents selected from:
- a) --C.sub.1-4 alkyl,
- b) halo,
- e) --OH,
- d) --CF.sub.3,
- e) --NH.sub.2,
- f) --NH(C.sub.1-4 alkyl),
- g) --N(C.sub.1-4 alkyl).sub.2,
- h) --CO.sub.2 H,
- i) --CO.sub.2 (C.sub.1-4 alkyl), and
- j) --C.sub.1-4 alkoxy;
- R.sup.1b is selected from:
- 1) R.sup.1a,
- 2) --C.sub.3-7 cycloalkyl, and
- 3) --CH.sub.2 --R.sup.1a ;
- R.sup.2a and R.sup.2b are independently phenyl, either unsubstituted or substituted with one or two substituents selected from:
- 1) --C.sub.1-4 alkoxy,
- 2) halo,
- 3) --OH,
- 4) --CF.sub.3,
- 5) --NH.sub.2,
- 6) --NH(C.sub.1-4 alkyl),
- 7) --N(C.sub.1-4 alkyl).sub.2,
- 8) --CO.sub.2 H,
- 9) --CO.sub.2 (C.sub.1-4 alkyl), and
- 10) --C.sub.1-6 alkyl, either unsubstituted or substituted with:
- a) halo,
- b) --OH,
- c) --CF.sub.3,
- d) --NH.sub.2,
- e) --NH(C.sub.1-4 alkyl),
- f) --N(C.sub.1-4 alkyl).sub.2,
- g) --CO.sub.2 H,
- h) --CO.sub.2 (C.sub.1-4 alkyl), and
- i) --C.sub.1-4 alkoxy,
- j) --S(O).sub.x (C.sub.1-4 alkyl) wherein X is 0, 1 or 2,
- k) --C.sub.3-7 cycloalkyl;
- and the phenyl groups of R.sup.2a and R.sup.2b may be joined together at the ortho carbon atoms through a carbon-carbon single bond or a C.sub.1-3 alkylene to form a tricyclic group with the X.sup.2 to which they are attached;
- X.sup.1 is --N, --CH or O, with the proviso that if X.sup.1 is O, R.sup.1a is absent;
- X.sup.2 is --N or --CH, with the proviso that if X.sup.1 is --CH, X.sup.2 is not --CH;
- R.sup.3 is
- 1) --C.sub.1-4 alkyl,
- 2) --CO.sub.2 R.sup.6,
- 3) --CH.sub.2 OCOR.sup.6,
- 4) --CH.sub.2 OH,
- 5) --CH.sub.2 OR.sup.5,
- 6) --CH.sub.2 S(O).sub.x R.sup.5,
- 7) --CH.sub.2 OCONR.sup.5 R.sup.6,
- 8) --CH.sub.2 CONR.sup.5 R.sup.6,
- 9) --CONR.sup.5 R.sup.6,
- 10) --CO.sub.2 R.sup.8,
- 11) --CH.sub.2 CO.sub.2 R.sup.6,
- 12) --CH.sub.2 CO.sub.2 R8,
- 13) --CONHSO.sub.2 R.sup.9,
- 14) --CH.sub.2 N(R.sup.6)CONR.sup.5 R.sup.6,
- 15) --CH.sub.2 NH.sub.2,
- 16) --CH.sub.2 NH(C.sub.1-4 alkyl), or
- 17) --CH.sub.2 N(C.sub.1-4 alkyl).sub.2 ;
- wherein
- R.sup.5 is C.sub.1-6 alkyl either unsubstituted or substituted with:
- 1) --halo,
- 2) --OH,
- 3) --CF.sub.3,
- 4) --NH.sub.2,
- 5) --NH(C.sub.1-4 alkyl),
- 6) --N(C.sub.1-4 alkyl).sub.2,
- 7) --CO.sub.2 H,
- 8) --CO.sub.2 (C.sub.1-4 alkyl),
- 9) --C.sub.3-7 cycloalkyl, or
- 10) phenyl, either unsubstituted or substituted with
- a) --C.sub.1-4 alkyl,
- b) --halo,
- c) --OH,
- d) --CF.sub.3,
- e) --NH.sub.2,
- f) --NH(C.sub.1-4 alkyl),
- g) --N(C.sub.1-4 alkyl).sub.2,
- h) --CO.sub.2 H, or
- i) --CO.sub.2 (C.sub.1-4 alkyl);
- R.sup.6 is --H or C.sub.1-4 alkyl;
- or
- R.sup.5 and R.sup.6 can be joined together to form with the nitrogen to which they are attached a ring of the formula --N(CH.sub.2 CH.sub.2).sub.2 L, wherein L is:
- i) a single bond,
- ii) --CH.sub.2 --,
- iii) --O--,
- iv) --S(O).sub.p --, or
- v) --NR.sup.7 ;
- R.sup.7 is
- 1) --H,
- 2) --C.sub.1-6 alkyl, unsubstituted or substituted with --OH, --C.sub.1-4 alkoxy, or --N(C.sub.1-4 alkyl).sub.2,
- 3) --aryl, wherein aryl is phenyl, either unsubstituted or substituted with
- a) --C.sub.1-4 alkyl,
- b) --halo,
- c) --OH,
- d) --CF.sub.3,
- e) --NH.sub.2,
- f) --NH(C.sub.1-4 alkyl),
- g) --N(C.sub.1-4 alkyl).sub.2,
- h) --CO.sub.2 H, or
- i) --CO.sub.2 (C.sub.1-4 alkyl);
- 4) --CH.sub.2 -aryl, wherein aryl is as defined above;
- R.sup.8 is
- 1) --H
- 2) ##STR24## wherein R.sup.10 is a) --C.sub.1-6 alkyl,
- b) --aryl, wherein aryl is as defined above, or
- c) --CH.sub.2 -aryl, wherein aryl is as defined above,
- 3) --CH.sub.2 -aryl, wherein aryl is as defined above;
- R.sup.9 is
- 1) --aryl, wherein aryl is as defined above,
- 2) --C.sub.3-7 cycloalkyl,
- 3) --polyfluoro-C.sub.1-4 alkyl
- 4) --C.sub.1-6 alkyl, either unsubstituted or substituted with
- a) --aryl, wherein aryl is as defined above,
- b) --OH,
- c) --SH,
- d) --C.sub.1-4 alkyl,
- e) --C.sub.3-7 cycloalkyl,
- f) --C.sub.1-4 alkoxy,
- g) --C.sub.1-4 alkylthio,
- h) --CF.sub.3,
- i) --halo,
- j) --NO.sub.2,
- k) --CO.sub.2 R.sup.6,
- l) --N(R.sup.6).sub.2, wherein the R.sup.6 groups are the same or different,
- m) --NH aryl,
- n) --N(aryl).sub.2,
- o) --PO.sub.3 H,
- p) --PO(OH)(OC.sub.1-4 alkyl) or
- q) a ring of the formula --N(CH.sub.2 CH.sub.2).sub.2 L, wherein L is as defined above;
- and
- R.sup.4 is H or R.sup.3.
144 more elements
Dependencies are inferred from the claim text.